Skip to main content
. 2021 Feb 2;14(Suppl 1):i14–i20. doi: 10.1093/ckj/sfab027

FIGURE 1:

FIGURE 1:

Distribution (%) of type of COVID-19 identification among KTx recipients (n = 338), HD (n = 861) and PD (n = 41) patients in ERACODA. Among symptomatic patients mortality rates were 22, 28 and 41%, respectively, for KTx, HD and PD patients, whereas mortality rates in patients identified by contact/routine screening were lower (19, 18 and 14%, respectively).